Trials / Completed
CompletedNCT04548128
Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS
Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3 utilizing techniques other than full median sternotomy (e.g. thoracotomy) and impact on post-implant length of stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HeartMate 3 Left Ventricular Assist System (HM3 LVAS) | This clinical trial investigates implant of the HM3 LVAS by techniques other than full median sternotomy. |
Timeline
- Start date
- 2020-11-17
- Primary completion
- 2022-07-19
- Completion
- 2022-12-20
- First posted
- 2020-09-14
- Last updated
- 2023-02-01
Locations
32 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT04548128. Inclusion in this directory is not an endorsement.